Irina Dudanova
Martinsried, BY 82152, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Anle138b ameliorates pathological phenotypes in mouse and cellular models of Huntington's disease.
Journal: EMBO molecular medicine
Published: March 05, 2025
Optogenetic restoration of neuron subtype-specific cortical activity ameliorates motor deficits in Huntington's Disease mice.
Journal: bioRxiv : the preprint server for biology
Published: February 20, 2025
α-Synuclein aggregates inhibit ESCRT-III through sequestration and collateral degradation.
Journal: Molecular cell
Published: January 22, 2025
Restoring cortical disinhibition improves Huntington's disease phenotypes.
Journal: Nature
Published: January 10, 2025
Neuroprotective effects of hepatoma-derived growth factor in models of Huntington's disease.
Journal: Life science alliance
Published: February 28, 2023
Distinct histological alterations of cortical interneuron types in mouse models of Huntington's disease.
Journal: Frontiers in neuroscience
Published: August 18, 2022
The AAA+ chaperone VCP disaggregates Tau fibrils and generates aggregate seeds in a cellular system.
The AAA+ chaperone VCP disaggregates Tau fibrils and generates aggregate seeds in a cellular system.
Journal: Nature communications
Published: February 21, 2022
Biosensors for Studying Neuronal Proteostasis.
Journal: Frontiers in molecular neuroscience
Published: December 05, 2021
Amyloid-like aggregating proteins cause lysosomal defects in neurons via gain-of-function toxicity.
Journal: Life science alliance
Published: August 05, 2021
The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model.
Journal: Nature communications
Published: January 26, 2021
Fluc-EGFP reporter mice reveal differential alterations of neuronal proteostasis in aging and disease.
Journal: The EMBO journal
Published: November 09, 2020
Last Updated: 09/26/2026